Advisors Preferred’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-807
| Closed | -$593K | – | 218 |
|
|
2022
Q3 | $593K | Sell |
807
-286
| -26% | -$210K | 0.3% | 24 |
|
|
2022
Q2 | $646K | Sell |
1,093
-6,749
| -86% | -$3.99M | 0.17% | 75 |
|
|
2022
Q1 | $5.45M | Buy |
7,842
+2,450
| +45% | +$1.7M | 0.44% | 27 |
|
|
2021
Q4 | $3.38M | Buy |
5,392
+3,269
| +154% | +$2.05M | 0.33% | 49 |
|
|
2021
Q3 | $1.21M | Buy |
+2,123
| New | +$1.21M | 0.17% | 52 |
|
|
2021
Q2 | – | Sell |
-3,785
| Closed | -$1.8M | – | 216 |
|
|
2021
Q1 | $1.8M | Buy |
+3,785
| New | +$1.8M | 0.26% | 34 |
|
|
2020
Q4 | – | Sell |
-2,121
| Closed | -$1.19M | – | 197 |
|
|
2020
Q3 | $1.19M | Buy |
2,121
+542
| +34% | +$303K | 0.24% | 29 |
|
|
2020
Q2 | $962K | Buy |
+1,579
| New | +$962K | 0.27% | 30 |
|
|
2020
Q1 | – | Sell |
-1,547
| Closed | -$581K | – | 232 |
|
|
2019
Q4 | $581K | Buy |
+1,547
| New | +$581K | 0.16% | 51 |
|